76 Page
Pharmacovigilance Guidance Document Marketing Authorization Holders of Pharmaceutical Products Published by Indian Pharmacopoeia Commission National Coordination Centre - Pharmacovigilance Programme of India
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Press Release IP-2018 - ipc.gov.in
www.ipc.gov.inPage 1 of 7 Press Release IP-2018 The latest Edition of Indian Pharmacopoeia, IP-2018 has been released on 29th September, 2017 by Sh. C.K. Mishra, Secretary Health & Family Welfare, Govt. of India in the presence of senior officers of
Addendum 2021 to Indian Pharmacopoeia 2018
www.ipc.gov.in17. Dolutegravir, Lamivudine and Tenofovir Disoproxil fumarate Tablets 18. Eplerenone Tablets 19. Etizolam 20. Etizolam Tablets 21. Favipiravir 22. Favipiravir Tablets 23. Ferrous Ascorbate 24. Ferrous Ascorbate and Folic Acid Suspension 25. Ferrous ascorbate and Folic Acid Tablets 26. Flunarizine Dihydrochloride 27. Flunarizine Tablets 28 ...
Addendum 2021 to Indian Pharmacopoeia 2018
www.ipc.gov.in96. Montelukast Sodium and Levocetrizine Hydrochloride Tablets 97. Multiple Electrolytes and Dextrose Injection Type I 98. Multiple Electrolytes and Dextrose Injection Type III 99. Niclosamide Tablets 100. Nimodipine 101. Nortriptyline Tablets 102. Nystatin 103. Olanzapine Tablets 104. Ondansetron Orally Disintegrating Tablets 105. Ormeloxifene ...
A GUIDANCE DOCUMENT for MEDICAL DEVICES
www.ipc.gov.inMinistry of Health & Family Welfare ... The term ―medical device‖ includes such technologically simple items as ice bags and tongue depressors on one end of the continuum and very ... device, assistive care device, diagnostic device and therapeutic device. Perhaps these are the
List of IP Reference Substances available at IPC, Ghaziabad
www.ipc.gov.in77. Brimonidine Tartrate IPRS/104/15 200 mg 78. Brinzolamide IPRS/107/14 200 mg 79. Bromhexine Hydrochloride IPRS/19/18 200 mg 80. Bronopol IPRS/07/20 200 mg 81. Buclizine Hydrochloride IPRS/53/19 200 mg 82. Budesonide IPRS/47/17 200 mg 83. Bupivacaine Hydrochloride IPRS/21/20 200 mg 84. Buspirone Hydrochloride IPRS/37/20 200 mg 85.
Related documents
Guidelines on good pharmacovigilance practices …
www.ema.europa.euGuidelines on good pharmacovigilance practices (GVP) – Introductory cover note EMA/213497/2017 Page 2/7 Background to GVP New legislation for pharmacovigilance applies in the European Union (EU) since July 2012, and to
Annual report of the Pharmacovigilance Inspectors …
www.ema.europa.euAnnual Report of the Pharmacovigilance Inspectors Working Group for 2016 EMA/INS/PHV/614022/2016 Page 2/12 Table of contents 1. Introduction.....3
Cognizant—Pharmacovigilance With Robotic …
www.cognizant.comTitle: Cognizant—Pharmacovigilance With Robotic Process Automation Author: Cognizant Subject: A major life sciences company wanted to …
Guideline on the Regulation of Therapeutic …
www.medsafe.govt.nz1.1 Legislation relating to pharmacovigilance. The following legislation should be read by the sponsor in conjunction with this part of the guideline.
Pharmacovigilance Systems ANALYSIS in Five …
apps.who.int2 comparative analysis of pharmacovigilance systems in five asian countries This report is made possible through an interagency agreement between the US Food and Drug Administration (FDA) and the US Agency for International Development (USAID).
pharmacovigilance requirements for biological …
www.cdsco.nic.inGuidance for industry on PharmacoviGilance requirements for BioloGical Products 4 AbbREviAtiOns 1. introduction 1.1 objective 1.2 Background 1.3 rationale
Pharmacovigilance guidelines Nov 2009 - Botswana
www.moh.gov.bw3 1 INTRODUCTION: Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related